Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00138255 · ClinicalTrials.gov registry record
Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines
A clinical trial, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- Terminated
- Registry status
- 32
- Enrollment target
NCT00138255 is a clinical trial that was terminated before completion, run by National Institute of Allergy and Infectious Diseases (NIAID). The registered enrollment target is 32 participants.
The verdict
NCT00138255 was terminated before completion, sponsored by National Institute of Allergy and Infectious Diseases (NIAID).
- TERMINATED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The purpose of this study is to see if the MMR and chickenpox vaccines work as well in premature infants as in children that were carried to full term. A group of children who were carried full-term will be matched for age, sex, and race and will be used for comparison.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2004-06 |
| Est. Completion | 2005-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00138255
The ClinicalTrials.gov registry entry for NCT00138255 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00138255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00138255 about?
NCT00138255 is a clinical study titled "Responses of Premature Infants to Measles-Mumps-Rubella (MMR) and Varicella Vaccines". The purpose of this study is to see if the MMR and chickenpox vaccines work as well in premature infants as in children that were carried to full term. A group of children who were carried full-term will be matched for age, sex, and race and will be used for comparison.
What is the current status of trial NCT00138255?
This trial is currently terminated. The enrollment target is 32 participants. The study started on 2004-06. Estimated completion is 2005-06.
Who is sponsoring clinical trial NCT00138255?
This trial is sponsored by National Institute of Allergy and Infectious Diseases (NIAID), which has 2,006 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.